Current status of minimally invasive surgery of gastroesophageal reflux disease

doi:10.16139/j.1007-9610.2023.03.006

Abstract

Abstract:

Gastroesophageal reflux disease (GERD) is one of the common gastrointestinal diseases. The treatment options for GERD includes lifestyle changes, medication, and surgery. With the development of surgical technology, minimally invasive surgery has become more and more widely used in clinical practice due to its advantages such as less trauma and rapid postoperative recovery. Laparoscopic fundoplication is the standard surgical treatment for GERD. Due to the postoperative complications of laparoscopic fundoplication, a variety of new alternative minimally invasive surgery methods, which are expected to provide new treatment options for GERD patients, have emerged recently. Surgical minimally invasive procedures include magnetic sphincter augmentation (MSA), bariatric surgery, and lower esophageal sphincter electric stimulating therapy (LES-EST). Endoscopic minimally invasive procedures include transoral incisionless fundoplication (TIF), Stretta radiofrequency ablation, and anti-reflux mucosectomy (ARMS). This article mainly describes the current status of minimally invasive surgical treatment of GERD.

Key words: Gastroesophageal reflux disease, Fundoplication, Minimally invasive surgery

CLC Number:

R573

Aikebaier·Aili , Yusujiang·Tusuntuoheti , Kelimu·Abudureyimu . Current status of minimally invasive surgery of gastroesophageal reflux disease[J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 208-214.

References 58

[1]	VAKIL N, VAN ZANTEN S V, KAHRILAS P, et al. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8):1900-1920. doi: 10.1111/ajg.2006.101.issue-8 URL
[2]	MIKAMI D J, MURAYAMA K M. Physiology and pathogenesis of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3):515-525. doi: 10.1016/j.suc.2015.02.006 URL
[3]	NIRWAN J S, HASAN S S, BABAR Z U, et al. Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis[J]. Sci Rep, 2020, 10(1):5814. doi: 10.1038/s41598-020-62795-1
[4]	TUERXUN K, BALATI M, AIMAITI M, et al. Epidemiological investigation, extraesophageal symptoms and risk factors of gastroesophageal reflux disease in Kashgar, Xinjiang, China[J]. Am J Transl Res, 2021, 13(12):14186-14194.
[5]	CHEN J, BRADY P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment[J]. Gastroenterol Nurs, 2019, 42(1):20-28. doi: 10.1097/SGA.0000000000000359 URL
[6]	CLARRETT D M, HACHEM C. Gastroesophageal reflux disease (GERD)[J]. Mo Med, 2018, 115(3):214-218.
[7]	GRALNEK I M, DULAI G S, FENNERTY M B, et al. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials[J]. Clin Gastroenterol Hepatol, 2006, 4(12):1452-1458. doi: 10.1016/j.cgh.2006.09.013 URL
[8]	RETTURA F, BRONZINI F, CAMPIGOTTO M, et al. Refractory gastroesophageal reflux disease: a management update[J]. Front Med (Lausanne), 2021, 8:765061.
[9]	NISSEN R, ROSSETTI M. Modern operations for hiatal hernia and reflux esophagitis: gastropexy and fundoplication[J]. Archivio Chir Torace, 1959, 13:375-387.
[10]	DALLEMAGNE B, WEERTS J M, JEHAES C, et al. Laparoscopic Nissen fundoplication: preliminary report[J]. Surg Laparosc Endosc, 1991, 1(3):138-143.
[11]	SALMINEN P, HURME S, OVASKA J. Fifteen-year outcome of laparoscopic and open Nissen fundoplication: a randomized clinical trial[J]. Ann Thorac Surg, 2012, 93(1):228-233. doi: 10.1016/j.athoracsur.2011.08.066 URL
[12]	CSENDES A, ORELLANA O, CUNEO N, et al. Long-term (15-year) objective evaluation of 150 patients after laparoscopic Nissen fundoplication[J]. Surgery, 2019, 166(5):886-894. doi: 10.1016/j.surg.2019.04.024 URL
[13]	HUMPHRIES L A, HERNANDEZ J M, CLARK W, et al. Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience[J]. Surg Endosc, 2013, 27(5):1537-1545. doi: 10.1007/s00464-012-2611-y URL
[14]	BROEDERS J A, ROKS D J, AHMED ALI U, et al. Laparoscopic anterior 180-degree versus Nissen fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials[J]. Ann Surg, 2013, 257(5):850-859. doi: 10.1097/SLA.0b013e31828604dd URL
[15]	HÅKANSON B S, LUNDELL L, BYLUND A, et al. Comparison of laparoscopic 270° posterior partial fundoplication vs. total fundoplication for the treatment of gastroesophageal reflux disease: a randomized clinical trial[J]. JAMA Surg, 2019, 154(6):479-486. doi: 10.1001/jamasurg.2019.0047 URL
[16]	HOPKINS R J, IRVINE T, JAMIESON G G, et al. Long-term follow-up of two randomized trials comparing laparoscopic Nissen 360° with anterior 90° partial fundoplication[J]. Br J Surg, 2020, 107(1):56-63. doi: 10.1002/bjs.11327 URL
[17]	RUDOLPH-STRINGER V, BRIGHT T, IRVINE T, et al. Randomized trial of laparoscopic Nissen versus anterior 180 degree partial fundoplication - late clinical outcomes at 15 to 20 years[J]. Ann Surg, 2022, 275(1):39-44. doi: 10.1097/SLA.0000000000004643 URL
[18]	MCKINLEY S K, DIRKS R C, WALSH D, et al. Surgical treatment of GERD: systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(8):4095-4123. doi: 10.1007/s00464-021-08358-5
[19]	KENNGOTT H G, FISCHER L, NICKEL F, et al. Status of robotic assistance—a less traumatic and more accurate minimally invasive surgery?[J]. Langenbecks Arch Surg, 2012, 397(3):333-341. doi: 10.1007/s00423-011-0859-7 URL
[20]	ROMERO P, NICKEL F, MANTEL M, et al. Intracorporal knot tying techniques—which is the right one?[J]. J Pediatr Surg, 2017, 52(4):633-638. doi: 10.1016/j.jpedsurg.2016.11.049 URL
[21]	CADIÈRE G B, HIMPENS J, VERTRUYEN M, et al. Nissen fundoplication done by remotely controlled robotic technique[J]. Ann Chir, 1999, 53(2):137-141.
[22]	LANG F, HUBER A, KOWALEWSKI K F, et al. Randomized controlled trial of robotic-assisted versus conventional laparoscopic fundoplication: 12 years follow-up[J]. Surg Endosc, 2022, 36(8):5627-5634. doi: 10.1007/s00464-021-08969-y
[23]	SUTER M. Gastroesophageal reflux disease, obesity, and Roux-en-Y gastric bypass: complex relationship—a narrative review[J]. Obes Surg, 2020, 30(8):3178-3187. doi: 10.1007/s11695-020-04690-2
[24]	JACOBSON B C, SOMERS S C, FUCHS C S, et al. Body mass index and symptoms of gastroesophageal reflux in women[J]. N Engl J Med, 2006, 354(22):2340-2348. doi: 10.1056/NEJMoa054391 URL
[25]	玉素江·图荪托合提, 艾克拜尔·艾力, 麦麦提艾力·麦麦提明, 等. 肥胖合并胃食管反流病的外科治疗研究进展[J]. 中华胃食管反流病电子杂志, 2022, 9(3):165-169.
	TUSUNTUOHETI Y, AILI A, MAIMAITIMING M, et al. Research progress of surgical treatment of obesity with gastroesophageal reflux disease[J]. Chin J GERD(Electronic Edition), 2022, 9(3):165-169.
[26]	VAN DE PAS K G H, BONOUVRIE D S, JANSSEN L, et al. Roux-en-Y gastric bypass versus sleeve gastrectomy in young adults: a dutch registry study[J]. Obes Surg, 2022, 32(3):763-770. doi: 10.1007/s11695-021-05846-4
[27]	PETERLI R, WÖLNERHANSSEN B K, PETERS T, et al. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial[J]. JAMA, 2018, 319(3):255-265. doi: 10.1001/jama.2017.20897 URL
[28]	PEREZ A R, MONCURE A C, RATTNER D W. Obesity adversely affects the outcome of antireflux operations[J]. Surg Endosc, 2001, 15(9):986-989. doi: 10.1007/s004640000392 URL
[29]	BHAT S, DUBEY N, GAN S W, et al. Efficacy and safety of laparoscopic Roux-en-Y gastric bypass in symptomatic patients following fundoplication failure: a meta-analysis[J]. Esophagus, 2022, 20(2):184-194. doi: 10.1007/s10388-022-00969-8
[30]	LEE W J, HAN M L, SER K H, et al. Laparoscopic Nissen fundoplication with gastric plication as a potential treatment of morbidly obese patients with GERD, first experience and results[J]. Obes Surg, 2014, 24(9):1447-1452. doi: 10.1007/s11695-014-1223-0 URL
[31]	OSPANOV O, MALECKAS A, OREKESHOVA A. Gastric greater curvature plication combined with Nissen fundoplication in the treatment of gastroesophageal reflux disease and obesity[J]. Medicina (Kaunas), 2016, 52(5):283-290.
[32]	DA SILVA L E, ALVES M M, EL-AJOUZ T K, et al. Laparoscopic sleeve-collis-Nissen gastroplasty: a safe alternative for morbidly obese patients with gastroesophageal reflux disease[J]. Obes Surg, 2015, 25(7):1217-1222. doi: 10.1007/s11695-014-1523-4 URL
[33]	艾克拜尔·艾力, 克力木·阿不都热依木, 张成, 等. 腹腔镜胃底折叠抗反流术联合胃袖状切除术动物实验研究[J]. 中国实用外科杂志, 2015, 35(2):211-213.
	AILI A, ABUDUREYIMU K, ZHANG C, et al. Establishment of laparoscopic fundoplication with sleeve gastrectomy in a porcine model[J]. Chin J Pract Surg, 2015, 35(2):211-213.
[34]	AILI A, MAIMAITIMING M, MAIMAITIYUSUFU P, et al. Gastroesophageal reflux related changes after sleeve gastrectomy and sleeve gastrectomy with fundoplication: a retrospective single center study[J]. Front Endocrinol (Lausanne), 2022, 13:1041889. doi: 10.3389/fendo.2022.1041889 URL
[35]	AZAGURY D, MORTON J. Surgical anti-reflux options beyond fundoplication[J]. Curr Gastroenterol Rep, 2017, 19(7):35. doi: 10.1007/s11894-017-0582-9 URL
[36]	BONAVINA L, DEMEESTER T R, GANZ R A. Linx™ reflux management system: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease[J]. Expert Rev Gastroenterol Hepatol, 2012, 6(6):667-674. doi: 10.1586/egh.12.47 URL
[37]	中国医疗保健国际交流促进会胃食管反流病学分会. 中国胃食管反流病多学科诊疗共识2022(二)[J]. 中华胃食管反流病电子杂志,2022, 9(3):112-146.
	Society of Gastroesophageal Reflux Disease, China International Exchange and Promotive Association for Medical and Health. Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022 (2)[J]. Chin J GERD(Electronic Edition),2022, 9(3):112-146
[38]	LOUIE B E, SMITH C D, SMITH C C, et al. Objective evidence of reflux control after magnetic sphincter augmentation: one year results from a post approval study[J]. Ann Surg, 2019, 270(2):302-308. doi: 10.1097/SLA.0000000000002789 URL
[39]	GANZ R A, EDMUNDOWICZ S A, TAIGANIDES P A, et al. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux[J]. Clin Gastroenterol Hepatol, 2016, 14(5):671-677. doi: 10.1016/j.cgh.2015.05.028 URL
[40]	WU H, ATTAAR M, WONG H J, et al. Impedance planimetry (EndoFLIP™) after magnetic sphincter augmentation (LINX^®) compared to fundoplication[J]. Surg Endosc, 2022, 36(10):7709-7716. doi: 10.1007/s00464-022-09128-7
[41]	REYNOLDS J L, ZEHETNER J, WU P, et al. Laparoscopic magnetic sphincter augmentation vs. laparoscopic Nissen fundoplication: a matched-pair analysis of 100 patients[J]. J Am Coll Surg, 2015, 221(1):123-128. doi: 10.1016/j.jamcollsurg.2015.02.025 URL
[42]	SKUBLENY D, SWITZER N J, DANG J, et al. LINX^® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Surg Endosc, 2017, 31(8):3078-3084. doi: 10.1007/s00464-016-5370-3 URL
[43]	SMITH C D, GANZ R A, LIPHAM J C, et al. Lower esophageal sphincter augmentation for gastroesophageal reflux disease: the safety of a modern implant[J]. J Laparoendosc Adv Surg Tech A, 2017, 27(6):586-591. doi: 10.1089/lap.2017.0025 URL
[44]	REAVIS K M, PERRY K A. Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease[J]. Expert Rev Med Devices, 2014, 11(4):341-350. doi: 10.1586/17434440.2014.925394 URL
[45]	RODRÍGUEZ L, RODRÍGUEZ P, NETO M G, et al. Short-term electrical stimulation of the lower esophageal sphincter increases sphincter pressure in patients with gastroesophageal reflux disease[J]. Neurogastroenterol Motil, 2012, 24(5):446-450. doi: 10.1111/nmo.2012.24.issue-5 URL
[46]	PAIREDER M, KRISTO I, ASARI R, et al. Effect of electrical stimulation therapy of the lower esophageal sphincter in GERD patients with ineffective esophageal motility[J]. Surg Endosc, 2021, 35(11):6101-6107. doi: 10.1007/s00464-020-08104-3
[47]	RODRÍGUEZ L, RODRIGUEZ P, GÓMEZ B, et al. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease[J]. Surgery, 2015, 157(3):556-567. doi: 10.1016/j.surg.2014.10.012 URL
[48]	IHDE G M. The evolution of TIF: transoral incisionless fundoplication[J]. Therap Adv Gastroenterol, 2020, 13:1756284820924206.
[49]	GERSON L, STOUCH B, LOBONŢIU A. Transoral incisionless fundoplication (TIF 2.0): a meta-analysis of three randomized, controlled clinical trials[J]. Chirurgia (Bucur), 2018, 113(2):173-184.
[50]	TRAD K S, BARNES W E, PREVOU E R, et al. The tempo trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective[J]. Surg Innov, 2018, 25(2):149-157. doi: 10.1177/1553350618755214 URL
[51]	TESTONI P A, TESTONI S, MAZZOLENI G, et al. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes[J]. Endoscopy, 2020, 52(6):469-473. doi: 10.1055/a-1124-3187 URL
[52]	TESTONI S G G, CILONA M B, MAZZOLENI G, et al. Transoral incisionless fundoplication with Medigus ultrasonic surgical endostapler (MUSE) for the treatment of gastro-esophageal reflux disease: outcomes up to 3 years[J]. Surg Endosc, 2022, 36(7):5023-5031. doi: 10.1007/s00464-021-08860-w
[53]	彭丽华, 杨云生, 万荣, 等. MUSE^TM内镜下胃底折叠术治疗13例胃食管反流病的疗效分析[J]. 中华消化杂志, 2018, 38(10):657-663.
	PENG L H, YANG Y S, WAN R, et al. Therapeutic effect of endoscopic anterior fundoplication by MUSE^TM in thirteen patients with gastroesophageal reflux disease[J]. Chin J Dig, 2018, 38(10):657-663.
[54]	LIANG W T, WU J M, WANG F, et al. Stretta radiofrequency for gastroesophageal reflux disease-related respiratory symptoms: a prospective 5-year study[J]. Minerva Chir, 2014, 69(5):293-299.
[55]	LIPKA S, KUMAR A, RICHTER J E. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(6):1058-1067. doi: 10.1016/j.cgh.2014.10.013 URL
[56]	FASS R, CAHN F, SCOTTI D J, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12):4865-4882. doi: 10.1007/s00464-017-5431-2 URL
[57]	DEBOURDEAU A, VITTON V, MONINO L, et al. Antireflux mucosectomy band (ARM-b) in treatment of refractory gastroesophageal reflux disease after bariatric surgery[J]. Obes Surg, 2020, 30(11):4654-4658. doi: 10.1007/s11695-020-04753-4
[58]	YEH J H, LEE C T, HSU M H, et al. Antireflux mucosal intervention (ARMI) procedures for refractory gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Therap Adv Gastroenterol, 2022, 15:17562848221094959.